{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:38:14Z","timestamp":1784302694873,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","award":["55000025"],"award-info":[{"award-number":["55000025"]}],"id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007273","name":"Weill Cornell Medical College","doi-asserted-by":"publisher","award":["TR000456-06"],"award-info":[{"award-number":["TR000456-06"]}],"id":[{"id":"10.13039\/100007273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11307-020-01501-z","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T13:02:48Z","timestamp":1589202168000},"page":"1600-1608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Multi-Ligand Imaging Study Exploring GABAergic Receptor Expression and Inflammation in Multiple Sclerosis"],"prefix":"10.1007","volume":"22","author":[{"given":"Yeona","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Milena Hurtado","family":"R\u00faa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike W.","family":"Kaunzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Nealon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paresh J.","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Vartanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Kuceyeski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4015-1781","authenticated-orcid":false,"given":"Susan A.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"1501_CR1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12974-017-0936-0","volume":"14","author":"SES Araujo","year":"2017","unstructured":"Araujo SES, Mendonca HR, Wheeler NA et al (2017) Inflammatory demyelination alters subcortical visual circuits. J Neuroinflammation 14:162","journal-title":"J Neuroinflammation"},{"key":"1501_CR2","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1093\/brain\/awv209","volume":"138","author":"N Cawley","year":"2015","unstructured":"Cawley N, Solanky BS, Muhlert N, Tur C, Edden RAE, Wheeler-Kingshott CAM, Miller DH, Thompson AJ, Ciccarelli O (2015) Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis. Brain 138:2584\u20132595","journal-title":"Brain"},{"key":"1501_CR3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.neuroimage.2017.01.033","volume":"157","author":"JC Nantes","year":"2017","unstructured":"Nantes JC, Proulx S, Zhong J, Holmes SA, Narayanan S, Brown RA, Hoge RD, Koski L (2017) GABA and glutamate levels correlate with MTR and clinical disability: insights from multiple sclerosis. NeuroImage 157:705\u2013715","journal-title":"NeuroImage"},{"key":"1501_CR4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.24468","volume":"78","author":"L Freeman","year":"2015","unstructured":"Freeman L, Garcia-Lorenzo D, Bottin L, Leroy C, Louapre C, Bodini B, Papeix C, Assouad R, Granger B, Tourbah A, Doll\u00e9 F, Lubetzki C, Bottlaender M, Stankoff B (2015) The neuronal component of gray matter damage in multiple sclerosis: a [(11) C]flumazenil positron emission tomography study. Ann Neurol 78:554\u2013567","journal-title":"Ann Neurol"},{"key":"1501_CR5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.celrep.2012.08.022","volume":"2","author":"DS Wang","year":"2012","unstructured":"Wang DS, Zurek AA, Lecker I, Yu J, Abramian AM, Avramescu S, Davies PA, Moss SJ, Lu WY, Orser BA (2012) Memory deficits induced by inflammation are regulated by alpha5-subunit-containing GABAA receptors. Cell Rep 2:488\u2013496","journal-title":"Cell Rep"},{"key":"1501_CR6","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.1074\/jbc.M512489200","volume":"281","author":"R Serantes","year":"2006","unstructured":"Serantes R, Arnalich F, Figueroa M, Salinas M, Andr\u00e9s-Mateos E, Codoceo R, Renart J, Matute C, Cavada C, Cuadrado A, Montiel C (2006) Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase\/Akt pathway: relevance to sepsis-associated encephalopathy. J Biol Chem 281:14632\u201314643","journal-title":"J Biol Chem"},{"key":"1501_CR7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neuroscience.2011.08.076","volume":"199","author":"MJ Bibolini","year":"2011","unstructured":"Bibolini MJ, Chanaday NL, Baez NS, Degano AL, Monferran CG, Roth GA (2011) Inhibitory role of diazepam on autoimmune inflammation in rats with experimental autoimmune encephalomyelitis. Neuroscience 199:421\u2013428","journal-title":"Neuroscience"},{"key":"1501_CR8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/glia.21087","volume":"59","author":"M Lee","year":"2011","unstructured":"Lee M, Schwab C, McGeer PL (2011) Astrocytes are GABAergic cells that modulate microglial activity. Glia 59:152\u2013165","journal-title":"Glia"},{"key":"1501_CR9","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1073\/pnas.0915139107","volume":"107","author":"R Bhat","year":"2010","unstructured":"Bhat R, Axtell R, Mitra A, Miranda M, Lock C, Tsien RW, Steinman L (2010) Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A 107:2580\u20132585","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1501_CR10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuroimage.2008.12.005","volume":"45","author":"I Odano","year":"2009","unstructured":"Odano I, Halldin C, Karlsson P, Varrone A, Airaksinen AJ, Krasikova RN, Farde L (2009) [18F]flumazenil binding to central benzodiazepine receptor studies by PET-quantitative analysis and comparisons with [11C]flumazenil. NeuroImage 45:891\u2013902","journal-title":"NeuroImage"},{"key":"1501_CR11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0020-708X(84)90215-1","volume":"35","author":"M Maziere","year":"1984","unstructured":"Maziere M, Hantraye P, Prenant C, Sastre J, Comar D (1984) Synthesis of ethyl 8-fluoro-5,6-dihydro-5-[11C]methyl-6-oxo-4H-imidazo [1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography. Int J Appl Radiat Isot 35:973\u2013976","journal-title":"Int J Appl Radiat Isot"},{"key":"1501_CR12","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1161\/01.STR.0000134746.93535.9b","volume":"35","author":"WD Heiss","year":"2004","unstructured":"Heiss WD, Sobesky J, Smekal U et al (2004) Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity: a comparative positron emission tomography\/magnetic resonance imaging study in early ischemic stroke. Stroke 35:1892\u20131898","journal-title":"Stroke"},{"key":"1501_CR13","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1212\/WNL.54.12.2252","volume":"54","author":"S Lamusuo","year":"2000","unstructured":"Lamusuo S, Pitkanen A, Jutila L, Ylinen A, Partanen K, Kalviainen R, Ruottinen HM, Oikonen V, Nagren K, Lehikoinen P, Vapalahti M, Vainio P, Rinne JO (2000) [11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology 54:2252\u20132260","journal-title":"Neurology"},{"key":"1501_CR14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12149-011-0480-4","volume":"25","author":"T Geeraerts","year":"2011","unstructured":"Geeraerts T, Coles JP, Aigbirhio FI, Pickard JD, Menon DK, Fryer TD, Hong YT (2011) Validation of reference tissue modelling for [11C]flumazenil positron emission tomography following head injury. Ann Nucl Med 25:396\u2013405","journal-title":"Ann Nucl Med"},{"key":"1501_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2009.10.015","volume":"221","author":"R Gandhi","year":"2010","unstructured":"Gandhi R, Laroni A, Weiner HL (2010) Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol 221:7\u201314","journal-title":"J Neuroimmunol"},{"issue":"Pt 11","key":"1501_CR16","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/brain\/123.11.2321","volume":"123","author":"RB Banati","year":"2000","unstructured":"Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123(Pt 11):2321\u20132337","journal-title":"Brain"},{"key":"1501_CR17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1212\/WNL.0b013e3182635645","volume":"79","author":"M Politis","year":"2012","unstructured":"Politis M, Giannetti P, Su P, Turkheimer F, Keihaninejad S, Wu K, Waldman A, Malik O, Matthews PM, Reynolds R, Nicholas R, Piccini P (2012) Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology 79:523\u2013530","journal-title":"Neurology"},{"key":"1501_CR18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2967\/jnumed.113.131698","volume":"55","author":"E Rissanen","year":"2014","unstructured":"Rissanen E, Tuisku J, Rokka J, Paavilainen T, Parkkola R, Rinne JO, Airas L (2014) In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand (1)(1)C-PK11195. Eur J Nucl Med 55:939\u2013944","journal-title":"Eur J Nucl Med"},{"key":"1501_CR19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage 9:179\u2013194","journal-title":"NeuroImage"},{"key":"1501_CR20","doi-asserted-by":"crossref","first-page":"e0201289","DOI":"10.1371\/journal.pone.0201289","volume":"13","author":"Y Kang","year":"2018","unstructured":"Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA (2018) Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11] PK11195. PLoS One 13:e0201289","journal-title":"PLoS One"},{"key":"1501_CR21","first-page":"207","volume":"23","author":"K Mikolajczyk","year":"1998","unstructured":"Mikolajczyk K, Szabatin M, Rudnicki P, Grodzki M, Burger C (1998) A JAVA environment for medical image data analysis: initial application for brain PET quantitation. Med Inf 23:207\u2013214","journal-title":"Med Inf"},{"key":"1501_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03164587","volume":"3","author":"K Hashimoto","year":"1989","unstructured":"Hashimoto K, Inoue O, Suzuki K, Yamasaki T, Kojima M (1989) Synthesis and evaluation of 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography. Ann Nucl Med 3:63\u201371","journal-title":"Ann Nucl Med"},{"key":"1501_CR23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jon.12519","volume":"28","author":"Y Kang","year":"2018","unstructured":"Kang Y, Mozley PD, Verma A, Schlyer D, Henchcliffe C, Gauthier SA, Chiao PC, He B, Nikolopoulou A, Logan J, Sullivan JM, Pryor KO, Hesterman J, Kothari PJ, Vallabhajosula S (2018) Noninvasive PK11195-PET image analysis techniques can detect abnormal cerebral microglial activation in Parkinson\u2019s disease. J Neuroimaging 28:496\u2013505","journal-title":"J Neuroimaging"},{"key":"1501_CR24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","volume":"16","author":"J Logan","year":"1996","unstructured":"Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834\u2013840","journal-title":"J Cereb Blood Flow Metab"},{"key":"1501_CR25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0969-8051(00)00137-2","volume":"27","author":"J Logan","year":"2000","unstructured":"Logan J (2000) Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol 27:661\u2013670","journal-title":"Nucl Med Biol"},{"key":"1501_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/brain\/awy296","volume":"142","author":"UW Kaunzner","year":"2019","unstructured":"Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Hurtado Rua SM, Park C, Gillen KM, Nguyen TD, Wang Y, Pitt D, Gauthier SA (2019) Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions. Brain 142:133\u2013145","journal-title":"Brain"},{"key":"1501_CR27","unstructured":"Team RC R: A language and environment for statistical computing. URL http:\/\/www.R-project.org\/"},{"key":"1501_CR28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate-a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 57:289\u2013300","journal-title":"J Roy Stat Soc B Met"},{"key":"1501_CR29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12021-013-9206-1","volume":"12","author":"E LoCastro","year":"2014","unstructured":"LoCastro E, Kuceyeski A, Raj A (2014) Brainography: an atlas-independent surface and network rendering tool for neural connectivity visualization. Neuriinformatics 12:355\u2013359","journal-title":"Neuriinformatics"},{"key":"1501_CR30","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/ejn.12534","volume":"39","author":"JM Fritschy","year":"2014","unstructured":"Fritschy JM, Panzanelli P (2014) GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system. Eur J Neurosci 39:1845\u20131865","journal-title":"Eur J Neurosci"},{"key":"1501_CR31","first-page":"31","volume":"8","author":"Y Li","year":"2016","unstructured":"Li Y, Sun H, Chen Z, Xu H, Bu G, Zheng H (2016) Implications of GABAergic neurotransmission in Alzheimer\u2019s disease. Front Aging Neurosci 8:31","journal-title":"Front Aging Neurosci"},{"key":"1501_CR32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20736","volume":"59","author":"R Dutta","year":"2006","unstructured":"Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, Gudz T, Macklin WB, Lewis DA, Fox RJ, Rudick R, Mirnics K, Trapp BD (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59:478\u2013489","journal-title":"Ann Neurol"},{"key":"1501_CR33","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1038\/ncomms4168","volume":"5","author":"MV Accardi","year":"2014","unstructured":"Accardi MV, Daniels BA, Brown PM, Fritschy JM, Tyagarajan SK, Bowie D (2014) Mitochondrial reactive oxygen species regulate the strength of inhibitory GABA-mediated synaptic transmission. Nat Commun 5:3168","journal-title":"Nat Commun"},{"key":"1501_CR34","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnen\/nlz028","volume":"78","author":"S Kiljan","year":"2019","unstructured":"Kiljan S, Prins M, Baselmans BM, Bol J, Schenk GJ, van Dam AM (2019) Enhanced GABAergic immunoreactivity in hippocampal neurons and astroglia of multiple sclerosis patients. J Neuropathol Exp Neurol 78:480\u2013491","journal-title":"J Neuropathol Exp Neurol"},{"key":"1501_CR35","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archneur.60.8.1082","volume":"60","author":"P Sarchielli","year":"2003","unstructured":"Sarchielli P, Greco L, Floridi A, Floridi A, Gallai V (2003) Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. Arch Neurol 60:1082\u20131088","journal-title":"Arch Neurol"},{"key":"1501_CR36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1750-3639.2007.00101.x","volume":"18","author":"J Newcombe","year":"2008","unstructured":"Newcombe J, Uddin A, Dove R, Patel B, Turski L, Nishizawa Y, Smith T (2008) Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 18:52\u201361","journal-title":"Brain Pathol"},{"key":"1501_CR37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.24202","volume":"76","author":"CJ Azevedo","year":"2014","unstructured":"Azevedo CJ, Kornak J, Chu P, Sampat M, Okuda DT, Cree BA, Nelson SJ, Hauser SL, Pelletier D (2014) In vivo evidence of glutamate toxicity in multiple sclerosis. Ann Neurol 76:269\u2013278","journal-title":"Ann Neurol"},{"key":"1501_CR38","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/nen.0b013e31812571b0","volume":"66","author":"M Vercellino","year":"2007","unstructured":"Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P (2007) Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 66:732\u2013739","journal-title":"J Neuropathol Exp Neurol"},{"key":"1501_CR39","doi-asserted-by":"crossref","unstructured":"Andersson JD, Matuskey D, Finnema SJ (2018) Positron emission tomography imaging of the gamma-aminobutyric acid system. Neurosci Lett","DOI":"10.1016\/j.neulet.2018.08.010"},{"key":"1501_CR40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/npp.2008.104","volume":"34","author":"WG Frankle","year":"2009","unstructured":"Frankle WG, Cho RY, Narendran R, Mason NS, Vora S, Litschge M, Price JC, Lewis DA, Mathis CA (2009) Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects. Neuropsychopharmacology 34:624\u2013633","journal-title":"Neuropsychopharmacology"},{"key":"1501_CR41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2990.2008.01006.x","volume":"35","author":"M Cosenza-Nashat","year":"2009","unstructured":"Cosenza-Nashat M, Zhao ML, Suh HS, Morgan J, Natividad R, Morgello S, Lee SC (2009) Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol 35:306\u2013328","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1501_CR42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1352458519885106","volume":"26","author":"J Zurawski","year":"2020","unstructured":"Zurawski J, Tauhid S, Chu R, Khalid F, Healy BC, Weiner HL, Bakshi R (2020) 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions. Mult Scler 26:177\u2013187","journal-title":"Mult Scler"},{"key":"1501_CR43","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrneurol.2015.222","volume":"11","author":"G Mandolesi","year":"2015","unstructured":"Mandolesi G, Gentile A, Musella A, Fresegna D, de Vito F, Bullitta S, Sepman H, Marfia GA, Centonze D (2015) Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis. Nat Rev Neurol 11:711\u2013724","journal-title":"Nat Rev Neurol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-020-01501-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-020-01501-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-020-01501-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T17:23:34Z","timestamp":1722878614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-020-01501-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1501"],"URL":"https:\/\/doi.org\/10.1007\/s11307-020-01501-z","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"11 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Kang reports no disclosures. Dr. Kaunzner reports no disclosures. Dr. Perumal reports no disclosures. Dr. Nealon reports no disclosures. Dr. Perumal has received consultant fees from Genzyme. Dr. Kothari reports no disclosures. Dr. Vartanian has received consultant fees from Biogen, Norvartis, and Genzyme as well as Celgene. Dr. Kuceyeski reports no disclosures. Hurtado R\u00faa reports no disclosures. Dr. Gauthier has grant support from Genzyme, Genentech, and Mallinckrodt and has also received consulting fees from Biogen, Genetech, and Celgene.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}